Article

Pain assessment: An alternative measure

A 21-numbered circle visual analog scale (VAS) may be a desirable alternative to the traditional 10-cm horizontal line for pain and patient global estimate on a Multidimensional Health Assessment Questionnaire (MDHAQ).

A 21-numbered circle visual analog scale (VAS) may be a desirable alternative to the traditional 10-cm horizontal line for pain and patient global estimate on a Multidimensional Health Assessment Questionnaire (MDHAQ). The results are similar, and less than half the time is required for scoring.

Pincus and colleagues conducted a study of patients with any diagnosis at 3 rheumatology clinical care institutions. Each patient completed the MDHAQ with VAS for pain and global estimate at each visit. VAS formats other than a traditional (unnumbered) 10-cm horizontal line based on 21 circles at 0.5-cm intervals were analyzed.

The median time to score MDHAQ with a 10-cm line VAS was 15.6 seconds, compared with 7.4 seconds for the 21-numbered circle VAS. Labeling of intermittent numerical rating values or different intermittent symbols from circles, designed to facilitate scoring, was affected by clustering.

The authors noted that the 21-circle format presents at least 3 advantages: (1) an assessor can score the VAS without a ruler, saving time; (2) the need to reproduce an exact 10-cm line is eliminated, avoiding the problem of distortion; and (3) patients appear to have a better understanding of how to respond to the 21 circles.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.